Customceutical Compounding Recalls TriMix MEDIUM Injectable Due to Sterility Concerns
Customceutical Compounding is recalling TriMix MEDIUM injectable compound due to a lack of assurance of sterility. The product was distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a sterile injectable product with a lack of sterility assurance is categorized as Severe (Score 4) due to the significant risk of infection or injury.
Plain-English summary
Customceutical Compounding is voluntarily recalling TriMix MEDIUM, a compounded injectable solution containing Papaverine HCL, Phentolamine Mesylate, and Alprostadil. The recall is being issued because there is a lack of assurance of sterility for the injectable solution.
The affected product is a 2 mL multidose vial. The specific lot number is 02182019@22, with an expiration date of 8/02/19. The product was distributed nationwide in the United States.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- TriMix MEDIUM (Papaverine HCL 21 mg/mL Phentolamine Mesylate 0.7 mg/mL Alprostadil 7 mcg/mL), 2 mL multidose MDV Inj. Compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272
- Manufacturer
- Customceutical Compounding
- Category
- Drug — Compounded Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 02182019@22
- Exp 8/02/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Customceutical Compounding under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Customceutical Compounding
See all →- SevereCustomceutical Compounding Recalls Glutathione Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls Lipoplex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls Test D Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls BPlex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls Test D Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29